Two Studies Showing New COVID-19 Boosters Similar to Old Shots Won’t Change Policy: FDA

Two Studies Showing New COVID-19 Boosters Similar to Old Shots Won’t Change Policy: FDA
Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, speaks in Washington on March 18, 2021. Susan Walsh/Pool/Getty Images
Zachary Stieber
Updated:
0:00

Two new studies that showed the updated COVID-19 boosters provoked an immune response similar to the one triggered by the old boosters will not have an effect on the U.S. Food and Drug Administration’s emergency use authorizations, a top regulator says.

Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research, told The Epoch Times via email that the studies were based on “small numbers of individuals” and that data from larger studies are expected to be available soon.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics